INDUSTRY RESEARCH

Market intelligence across pharma, MedTech, and digital health.

3,460+ published studies covering therapeutics, diagnostics, devices, and healthcare services — sized bottom-up and top-down, validated by our dedicated Healthcare & Medical Devices research team, and delivered with country-level detail.

3,460+ Published studies
9 Sub-domains tracked
100+ Countries covered
Weekly New titles added
Our expertise in this vertical

The Healthcare & Medical Devices Research Team

This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.

Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.

HC Reports in this section are prepared and reviewed by the Healthcare & Medical Devices research team.

Who we interview

Clinical KOLs, regulatory affairs heads, hospital procurement leads, and MedTech product & commercial teams.

Regulatory fluency

Analysts track FDA, EMA, and regional approval pathways so device and drug forecasts reflect real timelines.

Reimbursement modeling

Forecasts factor in payer policy and reimbursement shifts, not just clinical or technology adoption curves.

Coverage within this vertical

Sub-domains we track

Healthcare & Medical Devices reports on this site span the following sub-domains. Reports aren't filed under these as separate sub-categories yet — search or browse the full list below to find a specific market.

01

Pharmaceuticals

Small-molecule and branded/generic drug markets across therapeutic areas and dosage forms.

02

Biotechnology & Advanced Therapies

Cell and gene therapies, biologics, and next-generation biotech platforms.

03

Medical Devices

Diagnostic, surgical, monitoring, and implantable device categories across care settings.

04

Medical Diagnostics

In-vitro diagnostics, imaging, and point-of-care testing markets.

05

Analytical & Laboratory Technologies

Lab instrumentation, reagents, and analytical platforms used in research and clinical settings.

06

Healthcare IT & Digital Health

EHR platforms, telehealth, remote monitoring, and clinical software markets.

07

Clinical & Healthcare Services

Hospital operations, outpatient care, and healthcare service delivery models.

08

Veterinary Healthcare

Animal health diagnostics, pharmaceuticals, and veterinary device markets.

09

Life Science Research Tools

Instruments, reagents, and platforms supporting pharmaceutical and academic research.

These sub-domains describe the breadth of coverage in this vertical — the report list below isn't filterable by sub-domain. Use search or contact us if you're after a specific market.
Research intelligence

Secondary sources behind this vertical

Alongside primary interviews, every Healthcare & Medical Devices estimate is checked against these authoritative public and regulatory sources.

Secondary source Official website
World Health Organization (WHO) who.int ↗
U.S. Food & Drug Administration (FDA) fda.gov ↗
European Medicines Agency (EMA) ema.europa.eu ↗
Centers for Disease Control and Prevention (CDC) cdc.gov ↗
National Institutes of Health (NIH) nih.gov ↗
National Center for Biotechnology Information (NCBI) ncbi.nlm.nih.gov ↗
PubMed pubmed.ncbi.nlm.nih.gov ↗
ClinicalTrials.gov clinicaltrials.gov ↗
International Organization for Standardization (ISO) iso.org ↗
ASTM International astm.org ↗
Advanced Medical Technology Association (AdvaMed) advamed.org ↗
Medical Device Innovation Consortium (MDIC) mdic.org ↗
Biotechnology Innovation Organization (BIO) bio.org ↗
Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA) ifpma.org ↗
U.S. Pharmacopeia (USP) usp.org ↗
European Directorate for the Quality of Medicines & HealthCare (EDQM) edqm.eu ↗
World Organisation for Animal Health (WOAH) woah.org ↗
American Hospital Association (AHA) aha.org ↗
OECD Health oecd.org/health ↗
World Bank Data data.worldbank.org ↗
Showing 4491 – 4500 of 4,607 Industry Research reports
Industry Research

Becker's Nevus Market Size & Forecasts 2026-2035, By Segments (Patient Demographics, End User, Diagnosis Method, Treatment Type, Distribution Channel), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Solta Medical, Cynosure, Lumenis, Cutera, Syneron Medical)

Becker's Nevus Market size is forecast to climb from USD 1 billion in 2025 to USD 1.88 billion by 2035, expanding at a CAGR of over 6.5% during 2026-2035. Industry revenue in 2026...

Industry Research

Urine Test Strips Market Size & Forecasts 2026-2035, By Segments (Function, Application, Type, End-User), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Siemens Healthineers, Arkray, Roche Diagnostics, ACON Laboratories, EKF Diagnostics)

Urine Test Strips Market size is projected to grow steadily from USD 707.41 million in 2025 to USD 1.15 billion by 2035, demonstrating a CAGR exceeding 5% through the forecast peri...

Industry Research

Neurology Digital Therapeutics Market Size & Forecasts 2026-2035, By Segments (Product, End User, Indication), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Pear Therapeutics, Akili Interactive, Happify Health, Neuroscience Solutions, MedRhythms)

Neurology Digital Therapeutics Market size is expected to advance from USD 399.23 million in 2025 to USD 3.72 billion by 2035, registering a CAGR of more than 25% across 2026-2035....

Industry Research

Hemophilia B Gene Therapy Market Size & Forecasts 2026-2035, By Segments (Patient Age Group, Disease Severity), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (uniQure, CSL Behring, Spark Therapeutics, BioMarin Pharmaceutical, Freeline Therapeutics)

Hemophilia B Gene Therapy Market size is anticipated to rise from USD 750.38 million in 2025 to USD 6.24 billion by 2035, reflecting a CAGR surpassing 23.6% over the forecast horiz...

Industry Research

Slit Lamp Device Market Size & Forecasts 2026-2035, By Segments (Modality, Type, End User, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Haag-Streit, Carl Zeiss Meditec, Topcon, Nidek, Reichert)

Slit Lamp Device Market size is predicted to expand from USD 723.75 million in 2025 to USD 1.16 billion by 2035, with growth underpinned by a CAGR above 4.8% between 2026 and 2035....

Industry Research

Retail Pharmacy Market Size & Forecasts 2026-2035, By Segments (Product, Distribution Channel, Target Customers), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (CVS Health, Walgreens Boots Alliance, Kroger, Rite Aid, Albertsons Companies)

Retail Pharmacy Market size is estimated to increase from USD 825.91 billion in 2025 to USD 2.28 trillion by 2035, supported by a CAGR exceeding 10.7% during 2026-2035. In 2026, re...

Industry Research

Menstrual Cramps Treatment Market Size & Forecasts 2026-2035, By Segments (Dysmenorrhea Type, Treatment Type, Distribution Channel, Route of Administration), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Pfizer, Johnson & Johnson, Bayer, Novartis, Teva Pharmaceutical)

Menstrual Cramps Treatment Market size is projected to expand significantly, moving from USD 756.55 million in 2025 to USD 1.77 billion by 2035, with a CAGR of 8.9% during the 2026...

Industry Research

Eye Lens Market Size & Forecasts 2026-2035, By Segments (Application, Lens type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Johnson & Johnson, Bausch + Lomb, Alcon, Carl Zeiss Meditec, Hoya Corporation)

Eye Lens Market size is set to grow from USD 1.07 trillion in 2025 to USD 12.73 trillion by 2035, reflecting a CAGR greater than 28.1% through 2026-2035. Industry revenues in 2026...

Industry Research

Value-Based Healthcare Services Market Size & Forecasts 2026-2035, By Segments (Deployment, Model, End Use), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (McKesson, Cardinal Health, UnitedHealth Group, CVS Health, Optum)

Value-Based Healthcare Services Market size is forecasted to reach USD 1.37 trillion by 2035, rising from USD 179.54 billion in 2025, at a CAGR of more than 22.5% between 2026 and...

Industry Research

Neuroblastoma Treatment Market Size & Forecasts 2026-2035, By Segments (Distribution Channel, Therapy), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Johnson & Johnson, Novartis, Pfizer, Roche, Bristol-Myers Squibb)

Neuroblastoma Treatment Market size is likely to expand from USD 835.88 million in 2025 to USD 1.61 billion by 2035, posting a CAGR above 6.8% across 2026-2035. The industry’s reve...

Need an Industry Research study we haven't published yet?

Our Healthcare team scopes custom studies using the same interview network and validation framework — typically delivered in 2–3 weeks.